ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Device Pyrogenicity Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-26Z16641
Home | Market Reports | Health| Medical Devices & Equipment
Global Medical Device Pyrogenicity Testing Service Market Research Report 2024
BUY CHAPTERS

Global Medical Device Pyrogenicity Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-26Z16641
Report
November 2025
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurofins
Nelson Laboratories
Pacific Biolabs
GenScript
SGS Ltd
Sartorius
IUVO
Microcoat
Measurlabs
Charles River
TUV-SUD
Ethide Labs
Wickham Micro
MAT Research

Medical Device Pyrogenicity Testing Service Market

The global Medical Device Pyrogenicity Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Implantable Devices accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Medical Device Pyrogenicity Testing Service leading manufacturers including Eurofins, Nelson Laboratories, Pacific BioLabs, GenScript, SGS, Sartorius AG, Iuvo, Microcoat, Measurlabs, Charles River, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Device Pyrogenicity Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Medical Device Pyrogenicity Testing Service Market Report

Report Metric Details
Report Name Medical Device Pyrogenicity Testing Service Market
Segment by Type
  • Bacterial Endotoxin Testing
  • Monocyte Activation Testing
  • Others
Segment by Application
  • Implantable Devices
  • Blood-Contacting Devices
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins, Nelson Laboratories, Pacific BioLabs, GenScript, SGS, Sartorius AG, Iuvo, Microcoat, Measurlabs, Charles River, TUV SUD, MAT Research, Ethide Labs, Wickham Micro
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Medical Device Pyrogenicity Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Medical Device Pyrogenicity Testing Service Market report?

Ans: The main players in the Medical Device Pyrogenicity Testing Service Market are Eurofins, Nelson Laboratories, Pacific BioLabs, GenScript, SGS, Sartorius AG, Iuvo, Microcoat, Measurlabs, Charles River, TUV SUD, MAT Research, Ethide Labs, Wickham Micro

What are the Application segmentation covered in the Medical Device Pyrogenicity Testing Service Market report?

Ans: The Applications covered in the Medical Device Pyrogenicity Testing Service Market report are Implantable Devices, Blood-Contacting Devices, Others

What are the Type segmentation covered in the Medical Device Pyrogenicity Testing Service Market report?

Ans: The Types covered in the Medical Device Pyrogenicity Testing Service Market report are Bacterial Endotoxin Testing, Monocyte Activation Testing, Others

1 Study Coverage
1.1 Introduction to Medical Device Pyrogenicity Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Device Pyrogenicity Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Bacterial Endotoxin Testing
1.2.3 Monocyte Activation Testing
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Medical Device Pyrogenicity Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Implantable Devices
1.3.3 Blood-Contacting Devices
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Device Pyrogenicity Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Device Pyrogenicity Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Medical Device Pyrogenicity Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Medical Device Pyrogenicity Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Bacterial Endotoxin Testing Market Size by Players
3.3.2 Monocyte Activation Testing Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Medical Device Pyrogenicity Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medical Device Pyrogenicity Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medical Device Pyrogenicity Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Medical Device Pyrogenicity Testing Service Market Size by Type (2020-2031)
6.4 North America Medical Device Pyrogenicity Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medical Device Pyrogenicity Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Medical Device Pyrogenicity Testing Service Market Size by Type (2020-2031)
7.4 Europe Medical Device Pyrogenicity Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medical Device Pyrogenicity Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Medical Device Pyrogenicity Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Medical Device Pyrogenicity Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Medical Device Pyrogenicity Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medical Device Pyrogenicity Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Medical Device Pyrogenicity Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Medical Device Pyrogenicity Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medical Device Pyrogenicity Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins
11.1.1 Eurofins Corporation Information
11.1.2 Eurofins Business Overview
11.1.3 Eurofins Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.1.4 Eurofins Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Medical Device Pyrogenicity Testing Service Revenue by Product in 2024
11.1.6 Eurofins Medical Device Pyrogenicity Testing Service Revenue by Application in 2024
11.1.7 Eurofins Medical Device Pyrogenicity Testing Service Revenue by Geographic Area in 2024
11.1.8 Eurofins Medical Device Pyrogenicity Testing Service SWOT Analysis
11.1.9 Eurofins Recent Developments
11.2 Nelson Laboratories
11.2.1 Nelson Laboratories Corporation Information
11.2.2 Nelson Laboratories Business Overview
11.2.3 Nelson Laboratories Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.2.4 Nelson Laboratories Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 Nelson Laboratories Medical Device Pyrogenicity Testing Service Revenue by Product in 2024
11.2.6 Nelson Laboratories Medical Device Pyrogenicity Testing Service Revenue by Application in 2024
11.2.7 Nelson Laboratories Medical Device Pyrogenicity Testing Service Revenue by Geographic Area in 2024
11.2.8 Nelson Laboratories Medical Device Pyrogenicity Testing Service SWOT Analysis
11.2.9 Nelson Laboratories Recent Developments
11.3 Pacific BioLabs
11.3.1 Pacific BioLabs Corporation Information
11.3.2 Pacific BioLabs Business Overview
11.3.3 Pacific BioLabs Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.3.4 Pacific BioLabs Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Pacific BioLabs Medical Device Pyrogenicity Testing Service Revenue by Product in 2024
11.3.6 Pacific BioLabs Medical Device Pyrogenicity Testing Service Revenue by Application in 2024
11.3.7 Pacific BioLabs Medical Device Pyrogenicity Testing Service Revenue by Geographic Area in 2024
11.3.8 Pacific BioLabs Medical Device Pyrogenicity Testing Service SWOT Analysis
11.3.9 Pacific BioLabs Recent Developments
11.4 GenScript
11.4.1 GenScript Corporation Information
11.4.2 GenScript Business Overview
11.4.3 GenScript Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.4.4 GenScript Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 GenScript Medical Device Pyrogenicity Testing Service Revenue by Product in 2024
11.4.6 GenScript Medical Device Pyrogenicity Testing Service Revenue by Application in 2024
11.4.7 GenScript Medical Device Pyrogenicity Testing Service Revenue by Geographic Area in 2024
11.4.8 GenScript Medical Device Pyrogenicity Testing Service SWOT Analysis
11.4.9 GenScript Recent Developments
11.5 SGS
11.5.1 SGS Corporation Information
11.5.2 SGS Business Overview
11.5.3 SGS Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.5.4 SGS Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 SGS Medical Device Pyrogenicity Testing Service Revenue by Product in 2024
11.5.6 SGS Medical Device Pyrogenicity Testing Service Revenue by Application in 2024
11.5.7 SGS Medical Device Pyrogenicity Testing Service Revenue by Geographic Area in 2024
11.5.8 SGS Medical Device Pyrogenicity Testing Service SWOT Analysis
11.5.9 SGS Recent Developments
11.6 Sartorius AG
11.6.1 Sartorius AG Corporation Information
11.6.2 Sartorius AG Business Overview
11.6.3 Sartorius AG Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.6.4 Sartorius AG Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 Sartorius AG Recent Developments
11.7 Iuvo
11.7.1 Iuvo Corporation Information
11.7.2 Iuvo Business Overview
11.7.3 Iuvo Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.7.4 Iuvo Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Iuvo Recent Developments
11.8 Microcoat
11.8.1 Microcoat Corporation Information
11.8.2 Microcoat Business Overview
11.8.3 Microcoat Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.8.4 Microcoat Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 Microcoat Recent Developments
11.9 Measurlabs
11.9.1 Measurlabs Corporation Information
11.9.2 Measurlabs Business Overview
11.9.3 Measurlabs Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.9.4 Measurlabs Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Measurlabs Recent Developments
11.10 Charles River
11.10.1 Charles River Corporation Information
11.10.2 Charles River Business Overview
11.10.3 Charles River Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.10.4 Charles River Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 TUV SUD
11.11.1 TUV SUD Corporation Information
11.11.2 TUV SUD Business Overview
11.11.3 TUV SUD Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.11.4 TUV SUD Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 TUV SUD Recent Developments
11.12 MAT Research
11.12.1 MAT Research Corporation Information
11.12.2 MAT Research Business Overview
11.12.3 MAT Research Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.12.4 MAT Research Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 MAT Research Recent Developments
11.13 Ethide Labs
11.13.1 Ethide Labs Corporation Information
11.13.2 Ethide Labs Business Overview
11.13.3 Ethide Labs Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.13.4 Ethide Labs Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 Ethide Labs Recent Developments
11.14 Wickham Micro
11.14.1 Wickham Micro Corporation Information
11.14.2 Wickham Micro Business Overview
11.14.3 Wickham Micro Medical Device Pyrogenicity Testing Service Product Features and Attributes
11.14.4 Wickham Micro Medical Device Pyrogenicity Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 Wickham Micro Recent Developments
12 Medical Device Pyrogenicity Testing ServiceIndustry Chain Analysis
12.1 Medical Device Pyrogenicity Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medical Device Pyrogenicity Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medical Device Pyrogenicity Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Eurofins
Nelson Laboratories
Pacific Biolabs
GenScript
SGS Ltd
Sartorius
IUVO
Microcoat
Measurlabs
Charles River
TUV-SUD
Ethide Labs
Wickham Micro
MAT Research
List of Tables
 Table 1. Global Medical Device Pyrogenicity Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Medical Device Pyrogenicity Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Medical Device Pyrogenicity Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Medical Device Pyrogenicity Testing Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Medical Device Pyrogenicity Testing Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Medical Device Pyrogenicity Testing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Medical Device Pyrogenicity Testing Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Medical Device Pyrogenicity Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Device Pyrogenicity Testing Service as of 2024)
 Table 11. Global Medical Device Pyrogenicity Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Medical Device Pyrogenicity Testing Service Companies Headquarters
 Table 13. Global Medical Device Pyrogenicity Testing Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Medical Device Pyrogenicity Testing Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Medical Device Pyrogenicity Testing Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Medical Device Pyrogenicity Testing Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Medical Device Pyrogenicity Testing Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Medical Device Pyrogenicity Testing Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Medical Device Pyrogenicity Testing Service Growth Accelerators and Market Barriers
 Table 25. North America Medical Device Pyrogenicity Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Medical Device Pyrogenicity Testing Service Growth Accelerators and Market Barriers
 Table 27. Europe Medical Device Pyrogenicity Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Medical Device Pyrogenicity Testing Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Medical Device Pyrogenicity Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Medical Device Pyrogenicity Testing Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Medical Device Pyrogenicity Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Medical Device Pyrogenicity Testing Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Medical Device Pyrogenicity Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Eurofins Corporation Information
 Table 35. Eurofins Description and Major Businesses
 Table 36. Eurofins Product Features and Attributes
 Table 37. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Eurofins Revenue Proportion by Product in 2024
 Table 39. Eurofins Revenue Proportion by Application in 2024
 Table 40. Eurofins Revenue Proportion by Geographic Area in 2024
 Table 41. Eurofins Medical Device Pyrogenicity Testing Service SWOT Analysis
 Table 42. Eurofins Recent Developments
 Table 43. Nelson Laboratories Corporation Information
 Table 44. Nelson Laboratories Description and Major Businesses
 Table 45. Nelson Laboratories Product Features and Attributes
 Table 46. Nelson Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Nelson Laboratories Revenue Proportion by Product in 2024
 Table 48. Nelson Laboratories Revenue Proportion by Application in 2024
 Table 49. Nelson Laboratories Revenue Proportion by Geographic Area in 2024
 Table 50. Nelson Laboratories Medical Device Pyrogenicity Testing Service SWOT Analysis
 Table 51. Nelson Laboratories Recent Developments
 Table 52. Pacific BioLabs Corporation Information
 Table 53. Pacific BioLabs Description and Major Businesses
 Table 54. Pacific BioLabs Product Features and Attributes
 Table 55. Pacific BioLabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Pacific BioLabs Revenue Proportion by Product in 2024
 Table 57. Pacific BioLabs Revenue Proportion by Application in 2024
 Table 58. Pacific BioLabs Revenue Proportion by Geographic Area in 2024
 Table 59. Pacific BioLabs Medical Device Pyrogenicity Testing Service SWOT Analysis
 Table 60. Pacific BioLabs Recent Developments
 Table 61. GenScript Corporation Information
 Table 62. GenScript Description and Major Businesses
 Table 63. GenScript Product Features and Attributes
 Table 64. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. GenScript Revenue Proportion by Product in 2024
 Table 66. GenScript Revenue Proportion by Application in 2024
 Table 67. GenScript Revenue Proportion by Geographic Area in 2024
 Table 68. GenScript Medical Device Pyrogenicity Testing Service SWOT Analysis
 Table 69. GenScript Recent Developments
 Table 70. SGS Corporation Information
 Table 71. SGS Description and Major Businesses
 Table 72. SGS Product Features and Attributes
 Table 73. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. SGS Revenue Proportion by Product in 2024
 Table 75. SGS Revenue Proportion by Application in 2024
 Table 76. SGS Revenue Proportion by Geographic Area in 2024
 Table 77. SGS Medical Device Pyrogenicity Testing Service SWOT Analysis
 Table 78. SGS Recent Developments
 Table 79. Sartorius AG Corporation Information
 Table 80. Sartorius AG Description and Major Businesses
 Table 81. Sartorius AG Product Features and Attributes
 Table 82. Sartorius AG Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Sartorius AG Recent Developments
 Table 84. Iuvo Corporation Information
 Table 85. Iuvo Description and Major Businesses
 Table 86. Iuvo Product Features and Attributes
 Table 87. Iuvo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Iuvo Recent Developments
 Table 89. Microcoat Corporation Information
 Table 90. Microcoat Description and Major Businesses
 Table 91. Microcoat Product Features and Attributes
 Table 92. Microcoat Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Microcoat Recent Developments
 Table 94. Measurlabs Corporation Information
 Table 95. Measurlabs Description and Major Businesses
 Table 96. Measurlabs Product Features and Attributes
 Table 97. Measurlabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Measurlabs Recent Developments
 Table 99. Charles River Corporation Information
 Table 100. Charles River Description and Major Businesses
 Table 101. Charles River Product Features and Attributes
 Table 102. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Charles River Recent Developments
 Table 104. TUV SUD Corporation Information
 Table 105. TUV SUD Description and Major Businesses
 Table 106. TUV SUD Product Features and Attributes
 Table 107. TUV SUD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. TUV SUD Recent Developments
 Table 109. MAT Research Corporation Information
 Table 110. MAT Research Description and Major Businesses
 Table 111. MAT Research Product Features and Attributes
 Table 112. MAT Research Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. MAT Research Recent Developments
 Table 114. Ethide Labs Corporation Information
 Table 115. Ethide Labs Description and Major Businesses
 Table 116. Ethide Labs Product Features and Attributes
 Table 117. Ethide Labs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Ethide Labs Recent Developments
 Table 119. Wickham Micro Corporation Information
 Table 120. Wickham Micro Description and Major Businesses
 Table 121. Wickham Micro Product Features and Attributes
 Table 122. Wickham Micro Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Wickham Micro Recent Developments
 Table 124. Raw Materials Key Suppliers
 Table 125. Distributors List
 Table 126. Market Trends and Market Evolution
 Table 127. Market Drivers and Opportunities
 Table 128. Market Challenges, Risks, and Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources


List of Figures
 Figure 1. Medical Device Pyrogenicity Testing Service Product Picture
 Figure 2. Global Medical Device Pyrogenicity Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Bacterial Endotoxin Testing Product Picture
 Figure 4. Monocyte Activation Testing Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Medical Device Pyrogenicity Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Implantable Devices
 Figure 8. Blood-Contacting Devices
 Figure 9. Others
 Figure 10. Medical Device Pyrogenicity Testing Service Report Years Considered
 Figure 11. Global Medical Device Pyrogenicity Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Medical Device Pyrogenicity Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Medical Device Pyrogenicity Testing Service Revenue Market Share by Region (2020-2031)
 Figure 15. Global Medical Device Pyrogenicity Testing Service Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Bacterial Endotoxin Testing Revenue Market Share by Player in 2024
 Figure 18. Monocyte Activation Testing Revenue Market Share by Player in 2024
 Figure 19. Others Revenue Market Share by Player in 2024
 Figure 20. Global Medical Device Pyrogenicity Testing Service Revenue Market Share by Type (2020-2031)
 Figure 21. Global Medical Device Pyrogenicity Testing Service Revenue Market Share by Application (2020-2031)
 Figure 22. North America Medical Device Pyrogenicity Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 23. North America Top 5 Players Medical Device Pyrogenicity Testing Service Revenue (US$ Million) in 2024
 Figure 24. North America Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 25. North America Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 26. US Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 27. Canada Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Mexico Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 29. Europe Medical Device Pyrogenicity Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. Europe Top 5 Players Medical Device Pyrogenicity Testing Service Revenue (US$ Million) in 2024
 Figure 31. Europe Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 32. Europe Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 33. Germany Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 34. France Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 35. U.K. Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 36. Italy Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Russia Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Medical Device Pyrogenicity Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Top 8 Players Medical Device Pyrogenicity Testing Service Revenue (US$ Million) in 2024
 Figure 40. Asia-Pacific Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Asia-Pacific Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Indonesia Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 43. Japan Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 44. South Korea Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 45. Australia Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 46. India Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Indonesia Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Vietnam Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Malaysia Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Philippines Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Singapore Medical Device Pyrogenicity Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Central and South America Medical Device Pyrogenicity Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Central and South America Top 5 Players Medical Device Pyrogenicity Testing Service Revenue (US$ Million) in 2024
 Figure 54. Central and South America Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 55. Central and South America Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Brazil Medical Device Pyrogenicity Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 57. Argentina Medical Device Pyrogenicity Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 58. Middle East and Africa Medical Device Pyrogenicity Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Middle East and Africa Top 5 Players Medical Device Pyrogenicity Testing Service Revenue (US$ Million) in 2024
 Figure 60. South America Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Middle East and Africa Medical Device Pyrogenicity Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 62. GCC Countries Medical Device Pyrogenicity Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 63. Israel Medical Device Pyrogenicity Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 64. Egypt Medical Device Pyrogenicity Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 65. South Africa Medical Device Pyrogenicity Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 66. Medical Device Pyrogenicity Testing Service Industry Chain Mapping
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Pyrogenicity Testing Service Market Research Report 2024
Global Medical Device Microbial Testing Service Market Research Report 2024
Global Medical Device Microbial Ingress Testing Service Market Research Report 2024
Global Medical Gas Testing Service Market Research Report 2025
Global Medical Device Validation Service Market Research Report 2024
Global Commercial Medical Testing Services Market Research Report 2025
Global Thermal Properties Testing Service Market Research Report 2025
Global Pneumatic Testing Services Market Research Report 2024
Global Pyromuscial Market Research Report 2025
Global Medical Device Disinfection Service Market Research Report 2025
Medical Equipment Testing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Device Safety Testing Market Research Report 2025
Global Thermal Energy Testing Service Market Research Report 2024
Global Fire Testing Services Market Research Report 2025
Global Medical Device Calibration Service Market Research Report 2024
Global Recording Pyrometer Market Research Report 2024
Global Pyrotechnic Valve Market Research Report 2024
Medical Device Efficacy Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Device Testing Inspection and Certification Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Warming Device Market Research Report 2024

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions